A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction

Objective. This study aimed to establish a clinical prognostic nomogram for predicting major adverse cardiovascular events (MACEs) after primary percutaneous coronary intervention (PCI) among patients with ST-segment elevation myocardial infarction (STEMI). Methods. Information on 464 patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: Enfa Zhao, Hang Xie, Yushun Zhang
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Cardiovascular Therapeutics
Online Access:http://dx.doi.org/10.1155/2020/9416803
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553730963144704
author Enfa Zhao
Hang Xie
Yushun Zhang
author_facet Enfa Zhao
Hang Xie
Yushun Zhang
author_sort Enfa Zhao
collection DOAJ
description Objective. This study aimed to establish a clinical prognostic nomogram for predicting major adverse cardiovascular events (MACEs) after primary percutaneous coronary intervention (PCI) among patients with ST-segment elevation myocardial infarction (STEMI). Methods. Information on 464 patients with STEMI who performed PCI procedures was included. After removing patients with incomplete clinical information, a total of 460 patients followed for 2.5 years were randomly divided into evaluation (n = 324) and validation (n = 136) cohorts. A multivariate Cox proportional hazards regression model was used to identify the significant factors associated with MACEs in the evaluation cohort, and then they were incorporated into the nomogram. The performance of the nomogram was evaluated by the discrimination, calibration, and clinical usefulness. Results. Apelin-12 change rate, apelin-12 level, age, pathological Q wave, myocardial infarction history, anterior wall myocardial infarction, Killip’s classification > I, uric acid, total cholesterol, cTnI, and the left atrial diameter were independently associated with MACEs (all P<0.05). After incorporating these 11 factors, the nomogram achieved good concordance indexes of 0.758 (95%CI = 0.707–0.809) and 0.763 (95%CI = 0.689–0.837) in predicting MACEs in the evaluation and validation cohorts, respectively, and had well-fitted calibration curves. The decision curve analysis (DCA) revealed that the nomogram was clinically useful. Conclusions. We established and validated a novel nomogram that can provide individual prediction of MACEs for patients with STEMI after PCI procedures in a Chinese population. This practical prognostic nomogram may help clinicians in decision making and enable a more accurate risk assessment.
format Article
id doaj-art-221472c0d96149f8adccc6509b873cb9
institution Kabale University
issn 1755-5914
1755-5922
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Cardiovascular Therapeutics
spelling doaj-art-221472c0d96149f8adccc6509b873cb92025-02-03T05:53:17ZengWileyCardiovascular Therapeutics1755-59141755-59222020-01-01202010.1155/2020/94168039416803A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial InfarctionEnfa Zhao0Hang Xie1Yushun Zhang2Department of Structural Heart Disease, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Structural Heart Disease, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Structural Heart Disease, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaObjective. This study aimed to establish a clinical prognostic nomogram for predicting major adverse cardiovascular events (MACEs) after primary percutaneous coronary intervention (PCI) among patients with ST-segment elevation myocardial infarction (STEMI). Methods. Information on 464 patients with STEMI who performed PCI procedures was included. After removing patients with incomplete clinical information, a total of 460 patients followed for 2.5 years were randomly divided into evaluation (n = 324) and validation (n = 136) cohorts. A multivariate Cox proportional hazards regression model was used to identify the significant factors associated with MACEs in the evaluation cohort, and then they were incorporated into the nomogram. The performance of the nomogram was evaluated by the discrimination, calibration, and clinical usefulness. Results. Apelin-12 change rate, apelin-12 level, age, pathological Q wave, myocardial infarction history, anterior wall myocardial infarction, Killip’s classification > I, uric acid, total cholesterol, cTnI, and the left atrial diameter were independently associated with MACEs (all P<0.05). After incorporating these 11 factors, the nomogram achieved good concordance indexes of 0.758 (95%CI = 0.707–0.809) and 0.763 (95%CI = 0.689–0.837) in predicting MACEs in the evaluation and validation cohorts, respectively, and had well-fitted calibration curves. The decision curve analysis (DCA) revealed that the nomogram was clinically useful. Conclusions. We established and validated a novel nomogram that can provide individual prediction of MACEs for patients with STEMI after PCI procedures in a Chinese population. This practical prognostic nomogram may help clinicians in decision making and enable a more accurate risk assessment.http://dx.doi.org/10.1155/2020/9416803
spellingShingle Enfa Zhao
Hang Xie
Yushun Zhang
A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
Cardiovascular Therapeutics
title A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
title_full A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
title_fullStr A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
title_full_unstemmed A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
title_short A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
title_sort nomogram based on apelin 12 for the prediction of major adverse cardiovascular events after percutaneous coronary intervention among patients with st segment elevation myocardial infarction
url http://dx.doi.org/10.1155/2020/9416803
work_keys_str_mv AT enfazhao anomogrambasedonapelin12forthepredictionofmajoradversecardiovasculareventsafterpercutaneouscoronaryinterventionamongpatientswithstsegmentelevationmyocardialinfarction
AT hangxie anomogrambasedonapelin12forthepredictionofmajoradversecardiovasculareventsafterpercutaneouscoronaryinterventionamongpatientswithstsegmentelevationmyocardialinfarction
AT yushunzhang anomogrambasedonapelin12forthepredictionofmajoradversecardiovasculareventsafterpercutaneouscoronaryinterventionamongpatientswithstsegmentelevationmyocardialinfarction
AT enfazhao nomogrambasedonapelin12forthepredictionofmajoradversecardiovasculareventsafterpercutaneouscoronaryinterventionamongpatientswithstsegmentelevationmyocardialinfarction
AT hangxie nomogrambasedonapelin12forthepredictionofmajoradversecardiovasculareventsafterpercutaneouscoronaryinterventionamongpatientswithstsegmentelevationmyocardialinfarction
AT yushunzhang nomogrambasedonapelin12forthepredictionofmajoradversecardiovasculareventsafterpercutaneouscoronaryinterventionamongpatientswithstsegmentelevationmyocardialinfarction